CardieX Opens Pre-Orders for Heart Assessment Device in the US
CardieX Limited (ASX:CDX): When Will It Breakeven?
CardieX Ltd: 2024 Annual Report
CardieX Ltd: Appendix 4E
CardieX Obtains Up to AU$1.1 Million R&D Loan From Mitchell Asset Management
Regal Funds Reduces Stake in CardieX Ltd
Australian Shares Inch Down As Market Assesses RBA Policy Meeting Minutes
Cardiex Marks Two Milestones Toward Wearable Biomarker Technology Commercialization; Shares Up 5%
CARDIEX Secures Higher Credit Facility From C2 Ventures
CardieX Advances Trade Reinstatement Process With Australian Bourse
Cardiex Receives Full Settlement of Clinichain Clinical Trial Payments
CardieX Sets U.S. IPO at 1.33 Million ADSs Priced at $7.50-$8 Each
CardieX Files for IPO to Sell 1.3M ADSs at $7.50-$8.00/ADS
CardieX Selected for Medtech Innovator's 2023 Accelerator Cohort
CardieX Secures US FDA Clearance for Blood Pressure Monitoring Device
CardieX Advances to Final Phase of NIH's Inaugural RADx Tech for Maternal Health Challenge
Proactive news headlines including Surefire Resources, Theta Gold Mines, Aurumin Ltd and CardieX Ltd
No Data